![Chun-Su Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chun-Su Lee
Comptroller/Controller/Auditor bei NOVMETAPHARMA CO., LTD.
Vermögen: 222 677 $ am 31.05.2024
Profil
Chun-Su Lee is currently working as an Auditor at NovMetaPharma Co., Ltd.
and NovMetaHealth Co. Ltd.
He completed his undergraduate and graduate degrees from Korea University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
NOVMETAPHARMA CO., LTD.
0,44% | 30.06.2023 | 48 860 ( 0,44% ) | 222 677 $ | 31.05.2024 |
Aktive Positionen von Chun-Su Lee
Unternehmen | Position | Beginn |
---|---|---|
NOVMETAPHARMA CO., LTD. | Comptroller/Controller/Auditor | 31.03.2015 |
NovMetaHealth Co. Ltd.
![]() NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Comptroller/Controller/Auditor | 01.12.2018 |
Ausbildung von Chun-Su Lee
Korea University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NOVMETAPHARMA CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
NovMetaHealth Co. Ltd.
![]() NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |